In Fig. 6B , the separation lines between the gel lanes were poorly reproduced. Samples were run in the same gel and only select lanes are shown. In Fig. S3 , the merged control picture (upper right panel) was inadvertently taken from a repeat experiment. The "Experimental procedures" inadvertently left out details of the controls used for FACS experiments. In Fig. 2C , the labeled negative control refers to binding of the secondary antibody swine anti-rabbit IgG without preincubation with the rabbit anti-LDLR antibody. In Fig. 3 , the labeled control refers to HepG2 WT cells incubated without Dil-LDL, and the same control was used in Figs. S2 and S3. In Fig. 4B , the labeled negative control refers to HEK293 WT cells incubated without FITC-LDL. In Fig. 4 , C and D, the labeled control refers to CHO WT cells incubated without Dil-LDL. These errors have now been corrected and do not affect the results or conclusions of this work. 
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